Cancer immunotherapy focusing on the role of interleukins: A comprehensive and updated study

Pathol Res Pract. 2023 Sep:249:154732. doi: 10.1016/j.prp.2023.154732. Epub 2023 Aug 1.

Abstract

Cytokines bind to specific receptors on target cells to activate intracellular signaling pathways that control diverse cellular functions, such as proliferation, differentiation, migration, and death. They are essential for the growth, activation, and operation of immune cells and the control of immunological reactions to pathogens, cancer cells, and other dangers. Based on their structural and functional properties, cytokines can be roughly categorized into different families, such as the tumor necrosis factor (TNF) family, interleukins, interferons, and chemokines. Leukocytes produce interleukins, a class of cytokines that have essential functions in coordinating and communicating with immune cells. Cancer, inflammation, and autoimmunity are immune-related disorders brought on by dysregulation of cytokine production or signaling. Understanding cytokines' biology to create novel diagnostic, prognostic, and therapeutic methods for various immune-related illnesses is crucial. Different immune cells, including T cells, B cells, macrophages, and dendritic cells, and other cells in the body, including epithelial cells and fibroblasts, generate and secrete interleukins. The present study's main aim is to fully understand interleukins' roles in cancer development and identify new therapeutic targets and strategies for cancer treatment.

Keywords: Cancer; Immunotherapy; Interleukins; Signaling pathways.

Publication types

  • Review

MeSH terms

  • Cytokines / metabolism
  • Humans
  • Immunotherapy
  • Interleukins*
  • Neoplasms* / drug therapy
  • Tumor Necrosis Factor-alpha

Substances

  • Interleukins
  • Cytokines
  • Tumor Necrosis Factor-alpha